Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Kaleido Biosciences stock (KLDO)

Buy Kaleido Biosciences stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Kaleido Biosciences is a biotechnology business based in the US. Kaleido Biosciences shares (KLDO) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $0.00 – the same closing value as a week prior. Kaleido Biosciences employs 76 staff and has a trailing 12-month revenue of around $1.1 million.

Our top picks for where to buy Kaleido Biosciences stock

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Our pick for stock bonuses

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Get up to $1,000 in stock when you fund a new account within 30 days
  • Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%

How to buy Kaleido Biosciences stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – KLDO. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Kaleido Biosciences stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Product USFST Finder Score Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder score
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Finder score
Stocks, ETFs
$0
$0
N/A
Earn up to $300
Finder score
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Finder score
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
4.35%
Get up to $10,000 and transfer fees covered
loading

What is the Finder Score?

The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.

We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.

Read the full Finder Score breakdown

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Kaleido Biosciences stock price (PINK: KLDO)

Use our graph to track the performance of KLDO stocks over time.

Kaleido Biosciences shares at a glance

Information last updated 2024-12-18.
Latest market close$0.00
52-week range$0.00 - $0.07
50-day moving average $0.01
200-day moving average $0.00
Wall St. target price$22.00
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-2.16

Kaleido Biosciences price performance over time

Historical closes compared with the close of $0.0001 from 2024-12-19

1 week (2024-12-13) 0.0001
1 month (2024-11-21) 0.0001
3 months (2024-09-20) 0.0001
6 months (2024-06-21) 0.0001
1 year (2023-12-21) 0.0001
2 years (2022-12-21) -90.00%
3 years (2021-12-21) 2.96
5 years (2019-12-20) 5.38

Kaleido Biosciences financials

Revenue TTM $1.1 million
Gross profit TTM $-66,699,000
Return on assets TTM -99.93%
Return on equity TTM -580.57%
Profit margin 0%
Book value $0.25
Market Capitalization $4,262

TTM: trailing 12 months

Kaleido Biosciences share dividends

We're not expecting Kaleido Biosciences to pay a dividend over the next 12 months.

Kaleido Biosciences share price volatility

Over the last 12 months, Kaleido Biosciences's shares have ranged in value from as little as $0 up to $0.07. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Kaleido Biosciences's is 37.044. This would suggest that Kaleido Biosciences's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Kaleido Biosciences overview

Kaleido Biosciences, Inc. , a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of multi drug resistant infection, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and inflammatory bowel diseases. The company has collaboration agreements with Institute Gustave Roussy, Washington University, and Janssen. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.

Frequently asked questions

What percentage of Kaleido Biosciences is owned by institutions?
Currently 0.031% of Kaleido Biosciences shares are held by institutions.
How many people work for Kaleido Biosciences?
Latest data suggests 76 work at Kaleido Biosciences.
When does the fiscal year end for Kaleido Biosciences?
Kaleido Biosciences's fiscal year ends in December.
Where is Kaleido Biosciences based?
Kaleido Biosciences's address is: 65 Hayden Avenue, Lexington, MA, United States, 02421
What is Kaleido Biosciences's ISIN number?
Kaleido Biosciences's international securities identification number is: US4833471000
What is Kaleido Biosciences's CUSIP number?
Kaleido Biosciences's Committee on Uniform Securities Identification Procedures number is: 483347100

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site